Acquisition of Boston biotech for up to $120M a 'validation' of Ora's model
French drug developer NiCox S.A. last week announced plans to buy Aciex Therapeutics
Nicox to acquire Aciex Therapeutics, Inc.
Significant step forward in Nicox’s strategy of creating an international ophthalmic company built around therapeutics and diagnostics
It all adds up to Ora
Check out our latest Video
Ophthalmology Innovation Summit At ASCRS 2014
The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation
20 years of research and 10,000 patients: Ora dry eye system supports two largest exits in dry eye
Unprecedented year sets Ora up for record 2014
Intellectual property within the context of establishing and protecting market share
Ophthalmic Product Development Insights
Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)
Compound May Offer New Treatment Option for Millions of Patients with DES
ARVO: Sight set on world-class science
Theme of ‘life-changing research’ provides current data on retina, glaucoma, dry eye, and more